Absence of neuronal nitric oxide synthase (nNOS) as a pathological marker for the diagnosis of Becker muscular dystrophy with rod domain deletions

Neuropathology and Applied Neurobiology

Volumn 30, Issue 5, 2004, Pages 540-545

  Torelli, Silvia ^a   Brown, S C ^a   Jimenez Mallebrera, C ^a   Feng, L ^a   Muntoni, F ^a   Sewry, C A ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ROBERT JONES AND AGNES HUNT ORTHOPAEDIC HOSPITAL   (United Kingdom)

Author keywords

Becker muscular dystrophy; Diagnosis; Dystrophin; nNOS

Indexed keywords

ANTIBODY; CREATINE KINASE; DYSTROPHIN; NEURONAL NITRIC OXIDE SYNTHASE; UTROPHIN;

ANTIBODY LABELING; ARTICLE; BECKER MUSCULAR DYSTROPHY; CASE REPORT; CHILD; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DISEASE MARKER; DUCHENNE MUSCULAR DYSTROPHY; ENZYME ACTIVITY; EXON; GENE DELETION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MUSCLE WEAKNESS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION; SARCOLEMMA; SENSITIVITY AND SPECIFICITY;

BIOLOGICAL MARKERS; BIOPSY; CHILD; CHILD, PRESCHOOL; CREATINE KINASE; DIAGNOSIS, DIFFERENTIAL; DYSTROPHIN; HUMANS; IMMUNOHISTOCHEMISTRY; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; MUTATION; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; POLYMERASE CHAIN REACTION; SARCOLEMMA;

EID: 7044223308     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2990.2004.00561.x     Document Type: Article

References (17)

1. Emery AEH, Muntoni F. Duchenne Muscular Dystrophy. Oxford: Oxford University Press, 2003
2. Koenig M, Beggs AH, Moyer M, Scherpf S, Heindrich K, Bettecken T, Meng G, Muller CR, Lindlof M, Kaariainen H, De la Chapelle A, Kiuru A, Savontaus MI, Gilgenkrantz H, Recan D, Chelly J, Kaplan JC, Covone AE, Archidiacono N, Romeo C, Liechti-Gallati S, Schneider V, Braga S, Moser H, Darras B, Wrogemann K, Blonden LA, van Paassen HMB, van Ommen GJB, Kunkel LM. The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am J Hum Genet 1989; 45: 498-506
3. Monaco AP, Bertelson CJ, Liechti-Gallati S, Moser H, Kunkel LM. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics 1988; 2: 90-5
4. Grady RM, Grange RW, Lau KS, Maimone MM, Nichol MC, Stull JT, Sanes JR. Role for alpha-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies. Nat Cell Biol 1999; 1: 215-20
5. Brenman JE, Chao DS, Xia H, Aldape K, Bredt DS. Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell 1995; 82: 743-52
6. Sander M, Chavoshan B, Harris SA, Iannaccone ST, Stull JT, Thomas GD, Victor RG. Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy. Proc Natl Acad Sci 2000; 97: 13818-23
7. Bulman DE, Murphy EG, Zubrzycka-Gaarn EE, Worton RG, Ray PN. Differentiation of Duchenne and Beckermuscular dystrophy phenotypes with amino- and carboxy-terminal antisera specific for dystrophin. Am J Hum Genet 1991; 48: 295-304
8. Muntoni F, Mateddu A, Cianchetti C, Marrosu MG, Clerk A, Cau M, Congiu R, Cao A, Melis MA. Dystrophin analysis using a panel of anti-dystrophin antibodies in Duchenne and Becker muscular dystrophy. J Neurol Neurosurg Psychiatry 1993; 56: 26-31
9. Taylor J, Muntoni F, Dubowitz V, Sewry CA. The abnormal expression of utrophin in Duchenne and Becker mscular dystrophy is age related. Neuropathol Appl Neurobiol 1997; 23: 399-405
10. Dubowitz V. (ed.) Muscle Biopsy. A Practical Approach, 2nd edn. Eastbourne: Bailliere Tindall, 1985
11. Beggs AH, M. Koenig FM, Boyce, LM, Kunkel. Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction. Hum Genet 1990; 86: 45-8
12. Chamberlain JS, Gibbs RA, Ranier JE, Nguyen PN, Caskey CT. Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. Nucl Acids Res 1988; 16: 11141-56
13. Melis MA, Cau M, Muntoni F, Mateddu A, Galanello R, Boccone L, Deidda F, Loi D, Cao A. Elevation of serum creatine kinase as the only manifestation of an intragenic deletion of the dystrophin gene in three unrelated families. Eur J Paediatr Neurol 1998; 2: 255-61
14. Brenman JE, Chao DS, Gee SH, McGee AW, Craven SE, Santillano DR, Wu Z, Huang F, Xia H, Peters MF, Froehner SC, Bredt DS. Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alphal-syntrophin mediated by PDZ domains. Cell 1996; 84: 757-67
15. Chao DS, Gorospe JR, Brenman JE, Rafael JA, Peters MF, Froehner SC, Huffman EP, Chamberlain JS, Bredt DS. Selective loss of sarcolemmal nitric oxide synthase in Becker muscular dystrophy. J Exp Med 1996; 184: 609-18
16. Wells KE, Torelli S, Lu Q, Brown SC, Partridge T, Muntoni F, Wells DJ. Relocalization of neuronal nitric oxide synthase (nNOS) as a marker for complete restoration of the dystrophin associated protein complex in skeletal muscle. Neuromuscul Disord 2003; 13: 21-31
17. Crosbie RH, Barresi R, Campbell KP. Loss of sarcolemma nNOS in sarcoglycan-deficient muscle. FASEB J 2002; 16: 1786-91